FDA Advisory Panel Recommends Novavax Vaccine for Use in the US 

June 8, 2022 by Alexa Hornbeck
FDA Advisory Panel Recommends Novavax Vaccine for Use in the US 
FILE - In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The more traditional kind of COVID-19 vaccine moved a step closer to the U.S. market Tuesday, June 7, 2022. Advisers to the Food and Drug Administration voted to back shots made by Novavax for U.S. adults. If the FDA ultimately agrees, Novavax's option could become the nation's fourth COVID-19 vaccine. (Serum Institute of India for Novavax via AP, File)

The U.S. Food and Drug Administration recommended an emergency use authorization for a COVID-19 vaccine from Novavax, Inc. on Tuesday, the second non-mRNA–based vaccine to be used in the U.S.

The FDA held an all-day Vaccines and Related Biological Products Advisory Committee meeting on June 7, and a panel of vaccine experts voted 21-0, with one abstention, in favor of the vaccine for those 18 and older. 

Similar to flu vaccines, the Novavax shot uses recombinant proteins grown in cell cultures developed by the biotech company based in Gaithersburg, Maryland. 


Global health experts believe EUA approval from the FDA for the Novavax COVID-19 vaccine could potentially help change the minds of people who are still vaccine hesitant in the United States based on concerns over the mRNA technology used in other vaccines. 



Results from a February phase 3 clinical trial in the U.K. also show it is 83% effective against all COVID-19 infections, and 100% effective at combating severe disease.

Alexa can be reached at [email protected]

A+
a-

In The News

U.S. Senate
Political News
Political News

Health

Voting

Health

September 27, 2022
by TWN Staff
Study Confirms Link Between COVID Shot and Increased Menstrual Cycle Length

WASHINGTON — A new study has confirmed the findings of earlier research that linked COVID-19 vaccination with an average increase... Read More

WASHINGTON — A new study has confirmed the findings of earlier research that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The study, which was funded by the National Institutes of Health, included data from nearly 20,000 people... Read More

September 27, 2022
by TWN Staff
New York City to Abide by Judge’s Ruling on Vaccine Mandate — For Now

NEW YORK — The city of New York will abide by a judge’s order barring enforcement of its COVID-19 vaccine... Read More

NEW YORK — The city of New York will abide by a judge’s order barring enforcement of its COVID-19 vaccine mandate for members of its largest police union while the decision is being appealed. On Friday, Manhattan State Supreme Court Judge Lyle Frank ruled the city... Read More

Biogen Pays $900M to Settle Doctor Kickback Allegations

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying... Read More

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. The agreement announced Monday settles a whistleblower lawsuit brought by former... Read More

Teen Interest in Long-Lasting Birth Control Soars After Roe

Sixteen-year-old Adismarys Abreu had been discussing a long-lasting birth control implant with her mother for about a year as a... Read More

Sixteen-year-old Adismarys Abreu had been discussing a long-lasting birth control implant with her mother for about a year as a potential solution to increasing menstrual pain. Then Roe v. Wade was overturned, and Abreu joined the throng of teens rushing to their doctors as states began... Read More

September 26, 2022
by Dan McCue
Harvard Report Provides Tips on Bullying Chronic Inflammation

BOSTON — A new report from Harvard Medical School offers practical advice on how to deal with chronic, low-grade inflammation,... Read More

BOSTON — A new report from Harvard Medical School offers practical advice on how to deal with chronic, low-grade inflammation, an ailment that contributes to the development of cancer, cardiovascular disease and other life-threatening conditions. Currently, about three out of five people around the world die... Read More

September 26, 2022
by TWN Staff
Prenatal Steroid Treatment May Improve Survival for Extremely Preterm Infants

WASHINGTON — Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a... Read More

WASHINGTON — Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded by the National Institutes of Health.  Antenatal steroid therapy, given to women at risk of preterm delivery, causes the fetal lungs to mature and... Read More

News From The Well
scroll top